Adherence to nCPAP in patients with coronary disease and sleep apnea without sleepiness

Respiratory Medicine

Volumn 101, Issue 3, 2007, Pages 461-466

  Sampol, Gabriel ^a   Rodés, Gloria ^a   Romero, Odile ^a   Jurado, María José ^a   Lloberes, Patricia ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Coronary disease; Nasal continuous positive airway pressure; Sleep; Sleep apnea

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP APNEA SYNDROME; SOMNOLENCE; SYMPTOM;

AGED; CONTINUOUS POSITIVE AIRWAY PRESSURE; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SLEEP; SLEEP APNEA, OBSTRUCTIVE;

EID: 33846663543     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.07.007     Document Type: Article

References (39)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230-1235
2. American Thoracic Society. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Am J Respir Crit Care Med 150 (1994) 1738-1745
3. Jenkinson C., Davies R.J., Mullins R., and Stradling J.R. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 353 (1999) 2100-2105
4. Ballester E., Badia J.R., Hernandez L., et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159 (1999) 495-501
5. Gottlieb D.J., Whitney C.W., Bonekat W.H., et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 159 (1999) 502-507
6. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 (2001) 19-25
7. Peker Y., Hedner J., Norum J., Kraiczi H., and Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7 yr follow-up. Am J Respir Crit Care Med 166 (2002) 159-165
8. Martí S., Sampol G., Muñoz X., et al. Mortality in severe sleep apnoea-hypopnoea syndrome patients: impact of treatment. Eur Respir J 20 (2002) 1511-1518
9. Marín J.M., Carrizo S.J., Vicente E., and Agustí A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1946-1953
10. Schaffer H., Koehler U., Ploch T., and Peter J.H. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 111 (1997) 387-393
11. Peker Y., Hedner J., Kraiczi H., and Löth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162 (2000) 81-86
12. Peled N., Abinader E.G., Pillar G., Sharif D., and Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive airway pressure treatment. J Am Coll Cardiol 34 (1999) 1744-1749
13. Loube D.I., Gay P.C., Strohl K.P., Pack A.I., White D.P., and Collop N.A. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 115 (1999) 863-866
14. Monserrat J.M., Amilibia J., Barbé F., et al. Tratamiento del síndrome de las apneas-hipoapneas durante el sueño. Arch Bronconeumol 24 (1998) 206-208
15. McArdle N., Devereux G., Heidarnejad H., Engleman H., Mackay T.W., and Douglas N.J. Long-term use of CPAP for sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 159 (1999) 1108-1114
16. Rauscher H., Popp W., Wanke T., and Zwick H. Acceptance of CPAP therapy for sleep apnea. Chest 100 (1991) 1019-1023
17. Waldhorn R.E., Herrick T.W., Nguyen M.C., O'Donnell A.E., Sodero J., and Potolicchio S.J. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 97 (1990) 33-38
18. Meurice J.C., Dore P., Paquereau J., et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure tratment in sleep apnea syndrome. Chest 105 (1994) 429-433
19. Sin D.D., Mayers I., Man G.C.W., and Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 121 (2002) 430-435
20. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
21. Ferrer M., Vilagut G., Monasterio C., Montserrat J.M., Mayos M., and Alonso J. Medida del impacto de los trastornos del sueño: las versiones españolas del cuestionario funcional del sueño y de la escala de somnolencia de Epworth (Measurement of the perceived impact of sleep disorders: Spanish version of the functional outcomes sleep questionnaire and the Epworth sleepiness scale). Med Clin (Barc) 113 (1999) 250-255
22. International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association; 1990.
23. Tarlov A.R., Ware J.E., Greenfield S., Nelson E.C., Perrin E., and Zubkoff M. The medical outcomes study: an application of methods for monitoring the results of medical care. JAMA 262 (1989) 925-930
24. Alonso J., Regidor E., Barrio G., Prielto L., Rodríguez C., and de la Fuente L. Valores poblacionales de referencia de la versión española del Cuestionario de Salud SF-36 (Population reference values of the Spanish version of the Health Questionnaire SF-36.). Med Clin (Barc) 111 (1998) 410-416
25. Ware J.E., and Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol 51 (1998) 903-912
26. Charlson M.E., Pompei P., Ales K.L., and Mackenzie R. A new method of classifyng prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40 (1987) 373-383
27. Ballester E., Solans M., Vila X., et al. Evaluation of a portable respiratory recording device for detecting apnoeas and hypopnoeas in subjects from a general population. Eur Respir J 16 (2000) 123-127
28. American Sleep Disorders Association. Practice parameters for the indications for polysomnography and related procedures. Sleep 20 (1997) 406-422
29. Kazis L.E., Anderson J.J., and Meenan R.F. Effect sizes for interpreting changes in health status. Med Care 27 (1989) S178-S189
30. Cohen J. Statistical power analysis for the behavioral sciences (1977), Academic Press, New York
31. Barbé F., Mayoralas L.R., Duran J., et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized controlled trial. Ann Intern Med 134 (2001) 1015-1023
32. Lloberes P., Martí S., Sampol G., et al. Predictive factors of quality-of-life improvement and continuous positive airway pressure use in patients with sleep apnea-hypopnea syndrome: study at 1 yr. Chest 126 (2004) 1241-1247
33. Narkiewicz K., Kato M., Phillips B.G., Pesek C.A., Davison D.E., and Somers V.K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 (1999) 2332-2335
34. Schulz R., Mahmoudi S., Hattar K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162 (2000) 566-570
35. Lavie L., Hefetz A., Luboshitzky R., and Lavie P. Plasma levels of nitric oxide and l-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 21 (2003) 57-64
36. Chin K., Nakamura T., Shimizu K., et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109 (2000) 562-567
37. Bokinsky G., Miller M., Ault K., Husband P., and Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 108 (1995) 625-630
38. Harsch I.A., Schahin S.P., Radespiel-Tröger M., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169 (2004) 156-162
39. Milleron O., Pillière R., Foucher A., et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25 (2004) 728-734